(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PSMB9 mRNA] CTD PMID:31150632 1,3-dinitrobenzene affects expression EXP 6480464 3-dinitrobenzene affects the expression of PSMB9 mRNA CTD PMID:16988215 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PSMB9 mRNA CTD PMID:25380136 1-nitropyrene decreases expression ISO PSMB9 (Homo sapiens) 6480464 1-nitropyrene results in decreased expression of PSMB9 mRNA CTD PMID:19041380 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PSMB9 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PSMB9 mRNA and [Estradiol co-treated with TGFB1 protein] results in decreased expression of PSMB9 mRNA CTD PMID:19619570 and PMID:30165855 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PSMB9 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO PSMB9 (Homo sapiens) 6480464 Estradiol results in increased expression of PSMB9 mRNA CTD PMID:19619570 and PMID:21185374 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Psmb9 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,2,2-trichloroethanol multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [HLA-B protein alternative form co-treated with 2 more ... CTD PMID:36423715 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PSMB9 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PSMB9 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of PSMB9 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSMB9 mRNA CTD PMID:21215274 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PSMB9 mRNA CTD PMID:15644576 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO PSMB9 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSMB9 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Psmb9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PSMB9 mRNA CTD PMID:19933214 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of PSMB9 mRNA CTD PMID:14600272 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PSMB9 protein CTD PMID:34915118 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of PSMB9 mRNA CTD PMID:25380136 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of PSMB9 mRNA CTD PMID:21893156 4-hydroxyphenyl retinamide increases expression ISO Psmb9 (Mus musculus) 6480464 Fenretinide results in increased expression of PSMB9 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of PSMB9 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO PSMB9 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of PSMB9 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO PSMB9 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of PSMB9 exon CTD PMID:30157460 Aflatoxin G1 decreases expression ISO PSMB9 (Homo sapiens) 6480464 aflatoxin G1 results in decreased expression of PSMB9 protein CTD PMID:20381597 all-trans-retinoic acid increases expression ISO PSMB9 (Homo sapiens) 6480464 Tretinoin results in increased expression of PSMB9 mRNA CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PSMB9 mRNA CTD PMID:16483693 antirheumatic drug multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of PSMB9 mRNA CTD PMID:16817978 antirheumatic drug decreases expression ISO PSMB9 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of PSMB9 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO Psmb9 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PSMB9 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO PSMB9 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to PSMB9 mRNA] CTD PMID:32406909 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of PSMB9 gene CTD PMID:28931070 azathioprine decreases expression ISO PSMB9 (Homo sapiens) 6480464 Azathioprine results in decreased expression of PSMB9 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO Psmb9 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PSMB9 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO Psmb9 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of PSMB9 mRNA and Benzo(a)pyrene results in increased expression of PSMB9 protein CTD PMID:22228805 and PMID:23735875 benzo[a]pyrene increases expression ISO PSMB9 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of PSMB9 protein CTD PMID:32717239 benzo[a]pyrene multiple interactions ISO Psmb9 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PSMB9 mRNA] CTD PMID:22228805 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PSMB9 mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate decreases expression ISO Psmb9 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of PSMB9 mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PSMB9 mRNA CTD PMID:25181051 and PMID:32145629 bisphenol A decreases expression ISO PSMB9 (Homo sapiens) 6480464 bisphenol A results in decreased expression of PSMB9 protein CTD PMID:31675489 bisphenol A multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PSMB9 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PSMB9 mRNA CTD PMID:34947998 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PSMB9 gene CTD PMID:28505145 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PSMB9 mRNA CTD PMID:24136188 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PSMB9 mRNA CTD PMID:19167457 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PSMB9 mRNA CTD PMID:33453195 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PSMB9 mRNA CTD PMID:25993096 calcitriol decreases expression ISO PSMB9 (Homo sapiens) 6480464 Calcitriol results in decreased expression of PSMB9 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO Psmb9 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube affects expression ISO Psmb9 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of PSMB9 mRNA CTD PMID:23125180 chloroprene decreases expression ISO Psmb9 (Mus musculus) 6480464 Chloroprene results in decreased expression of PSMB9 mRNA CTD PMID:23125180 chromium(6+) affects expression ISO Psmb9 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of PSMB9 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO Psmb9 (Mus musculus) 6480464 Ciguatoxins affects the expression of PSMB9 mRNA CTD PMID:18353800 cisplatin decreases response to substance ISO PSMB9 (Homo sapiens) 6480464 PSMB9 mRNA results in decreased susceptibility to Cisplatin CTD PMID:23165153 cisplatin multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PSMB9 mRNA CTD PMID:27392435 cisplatin increases expression ISO PSMB9 (Homo sapiens) 6480464 Cisplatin results in increased expression of PSMB9 mRNA CTD PMID:23165153 more ... clofibrate decreases expression ISO Psmb9 (Mus musculus) 6480464 Clofibrate results in decreased expression of PSMB9 mRNA CTD PMID:23811191 cobalt dichloride increases expression ISO Psmb9 (Mus musculus) 6480464 cobaltous chloride results in increased expression of PSMB9 mRNA CTD PMID:21139344 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PSMB9 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO PSMB9 (Homo sapiens) 6480464 Cyclosporine results in increased expression of PSMB9 mRNA CTD PMID:20106945 and PMID:22147139 dexamethasone decreases expression ISO PSMB9 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of PSMB9 mRNA CTD PMID:31209803 dexamethasone multiple interactions ISO PSMB9 (Homo sapiens) 6480464 N-(oxo-5 more ... CTD PMID:31209803 dicrotophos decreases expression ISO PSMB9 (Homo sapiens) 6480464 dicrotophos results in decreased expression of PSMB9 mRNA CTD PMID:28302478 diquat decreases expression ISO Psmb9 (Mus musculus) 6480464 Diquat results in decreased expression of PSMB9 mRNA CTD PMID:36851058 diuron decreases expression ISO PSMB9 (Homo sapiens) 6480464 Diuron results in decreased expression of PSMB9 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB9 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO Psmb9 (Mus musculus) 6480464 Doxorubicin results in decreased expression of PSMB9 mRNA and Doxorubicin results in decreased expression of PSMB9 protein CTD PMID:25896364 doxorubicin increases expression ISO Psmb9 (Mus musculus) 6480464 Doxorubicin results in increased expression of PSMB9 mRNA CTD PMID:27155237 doxorubicin multiple interactions ISO Psmb9 (Mus musculus) 6480464 PSMB9 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] more ... CTD PMID:25896364 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PSMB9 mRNA CTD PMID:29391264 entinostat increases expression ISO PSMB9 (Homo sapiens) 6480464 entinostat results in increased expression of PSMB9 mRNA CTD PMID:27188386 fulvestrant multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PSMB9 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PSMB9 mRNA CTD PMID:22061828 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PSMB9 mRNA CTD PMID:24395379 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of PSMB9 mRNA CTD PMID:16452686 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of PSMB9 mRNA CTD PMID:23153324 hydralazine multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB9 mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO Psmb9 (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of PSMB9 protein CTD PMID:22308036 inulin multiple interactions ISO Psmb9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PSMB9 mRNA CTD PMID:36331819 ivermectin decreases expression ISO PSMB9 (Homo sapiens) 6480464 Ivermectin results in decreased expression of PSMB9 protein CTD PMID:32959892 lead diacetate decreases expression ISO Psmb9 (Mus musculus) 6480464 lead acetate results in decreased expression of PSMB9 mRNA CTD PMID:22609695 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of PSMB9 mRNA CTD PMID:24136188 lipopolysaccharide increases expression ISO Psmb9 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of PSMB9 mRNA CTD PMID:27339419 lithium atom increases expression EXP 6480464 Lithium results in increased expression of PSMB9 protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of PSMB9 protein CTD PMID:18296634 methotrexate multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of PSMB9 mRNA CTD PMID:16817978 methylmercury chloride decreases expression ISO Psmb9 (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of PSMB9 mRNA CTD PMID:20061341 microcystin RR decreases expression ISO PSMB9 (Homo sapiens) 6480464 microcystin RR results in decreased expression of PSMB9 protein CTD PMID:19111056 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO Psmb9 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PSMB9 mRNA CTD PMID:20061341 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO PSMB9 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMB9 mRNA CTD PMID:31806706 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PSMB9 mRNA CTD PMID:14600272 and PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PSMB9 mRNA CTD PMID:24136188 nickel atom increases expression ISO PSMB9 (Homo sapiens) 6480464 Nickel results in increased expression of PSMB9 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO PSMB9 (Homo sapiens) 6480464 nickel sulfate results in increased expression of PSMB9 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PSMB9 mRNA CTD PMID:24136188 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PSMB9 mRNA CTD PMID:17202759 paracetamol decreases expression ISO PSMB9 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PSMB9 mRNA CTD PMID:21420995 paracetamol affects expression ISO Psmb9 (Mus musculus) 6480464 Acetaminophen affects the expression of PSMB9 mRNA CTD PMID:17562736 parathion decreases expression ISO Psmb9 (Mus musculus) 6480464 Parathion results in decreased expression of PSMB9 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO Psmb9 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of PSMB9 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO Psmb9 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of PSMB9 mRNA and perfluorooctane sulfonic acid results in decreased expression of PSMB9 protein CTD PMID:20936131 and PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions ISO Psmb9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PSMB9 mRNA CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PSMB9 mRNA CTD PMID:21318169 phenylmercury acetate decreases expression ISO PSMB9 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of PSMB9 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB9 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of PSMB9 mRNA CTD PMID:15215175 pirinixic acid multiple interactions ISO Psmb9 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PSMB9 mRNA more ... CTD PMID:18467677 more ... pirinixic acid decreases expression ISO Psmb9 (Mus musculus) 6480464 pirinixic acid results in decreased expression of PSMB9 mRNA CTD PMID:17426115 more ... pirinixic acid increases expression ISO Psmb9 (Mus musculus) 6480464 pirinixic acid results in increased expression of PSMB9 mRNA CTD PMID:18467677 pyrrolidine dithiocarbamate multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [pyrrolidine dithiocarbamic acid co-treated with HLA-B protein alternative form] results in decreased expression of PSMB9 protein more ... CTD PMID:36423715 quartz decreases expression ISO PSMB9 (Homo sapiens) 6480464 Quartz results in decreased expression of PSMB9 mRNA more ... CTD PMID:35506645 quartz multiple interactions ISO PSMB9 (Homo sapiens) 6480464 PSMB9 inhibits the reaction [Quartz results in decreased expression of BCL2 protein] more ... CTD PMID:35506645 quartz decreases expression ISO Psmb9 (Mus musculus) 6480464 Quartz results in decreased expression of PSMB9 mRNA CTD PMID:35506645 quercitrin decreases expression ISO PSMB9 (Homo sapiens) 6480464 quercitrin results in decreased expression of PSMB9 mRNA CTD PMID:25193878 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PSMB9 mRNA CTD PMID:28374803 salicylic acid increases expression ISO PSMB9 (Homo sapiens) 6480464 Salicylic Acid results in increased expression of PSMB9 mRNA CTD PMID:23165153 SB 431542 multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB9 mRNA CTD PMID:27188386 serpentine asbestos increases expression ISO PSMB9 (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of PSMB9 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO PSMB9 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of PSMB9 mRNA and Silicon Dioxide results in increased expression of PSMB9 mRNA CTD PMID:25351596 and PMID:25895662 silver atom decreases expression ISO Psmb9 (Mus musculus) 6480464 Silver results in decreased expression of PSMB9 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Psmb9 (Mus musculus) 6480464 Silver results in decreased expression of PSMB9 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of PSMB9 promoter CTD PMID:18448484 sodium arsenite increases expression ISO Psmb9 (Mus musculus) 6480464 sodium arsenite results in increased expression of PSMB9 mRNA CTD PMID:17350061 sodium dodecyl sulfate decreases expression ISO PSMB9 (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in decreased expression of PSMB9 mRNA CTD PMID:31734321 Soman increases expression EXP 6480464 Soman results in increased expression of PSMB9 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PSMB9 mRNA CTD PMID:36139627 sulfasalazine decreases expression EXP 6480464 Sulfasalazine results in decreased expression of PSMB9 mRNA CTD PMID:17202759 tamibarotene increases expression ISO PSMB9 (Homo sapiens) 6480464 tamibarotene results in increased expression of PSMB9 mRNA CTD PMID:15498508 tamoxifen affects expression ISO Psmb9 (Mus musculus) 6480464 Tamoxifen affects the expression of PSMB9 mRNA CTD PMID:20937368 tert-butyl hydroperoxide increases expression ISO Psmb9 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of PSMB9 mRNA CTD PMID:15003993 testosterone increases expression ISO Psmb9 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of PSMB9 mRNA CTD PMID:33848595 testosterone multiple interactions ISO Psmb9 (Mus musculus) 6480464 1 more ... CTD PMID:33848595 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PSMB9 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO Psmb9 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of PSMB9 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PSMB9 mRNA CTD PMID:31150632 theophylline affects expression EXP 6480464 Theophylline affects the expression of PSMB9 mRNA CTD PMID:16988215 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PSMB9 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Psmb9 (Mus musculus) 6480464 titanium dioxide results in increased expression of PSMB9 mRNA CTD PMID:23409001 titanium dioxide decreases expression ISO Psmb9 (Mus musculus) 6480464 titanium dioxide results in decreased expression of PSMB9 mRNA CTD PMID:27760801 tolfenamic acid increases expression ISO PSMB9 (Homo sapiens) 6480464 tolfenamic acid results in increased expression of PSMB9 mRNA CTD PMID:23165153 trametinib multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PSMB9 mRNA CTD PMID:36139627 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PSMB9 mRNA CTD PMID:19448997 trichostatin A decreases expression ISO PSMB9 (Homo sapiens) 6480464 trichostatin A results in decreased expression of PSMB9 mRNA CTD PMID:24935251 trichostatin A increases expression ISO PSMB9 (Homo sapiens) 6480464 trichostatin A results in increased expression of PSMB9 mRNA CTD PMID:24935251 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of PSMB9 mRNA CTD PMID:21893156 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PSMB9 protein CTD PMID:32519852 triptonide increases expression ISO Psmb9 (Mus musculus) 6480464 triptonide results in increased expression of PSMB9 mRNA CTD PMID:33045310 valproic acid multiple interactions ISO PSMB9 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB9 mRNA CTD PMID:17183730 valproic acid increases expression ISO PSMB9 (Homo sapiens) 6480464 Valproic Acid results in increased expression of PSMB9 mRNA CTD PMID:23527032 more ... valproic acid affects expression ISO PSMB9 (Homo sapiens) 6480464 Valproic Acid affects the expression of PSMB9 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of PSMB9 mRNA CTD PMID:21318169 valproic acid increases expression ISO Psmb9 (Mus musculus) 6480464 Valproic Acid results in increased expression of PSMB9 mRNA CTD PMID:21427059 vancomycin decreases expression ISO Psmb9 (Mus musculus) 6480464 Vancomycin results in decreased expression of PSMB9 mRNA CTD PMID:18930951 vitamin E increases expression ISO PSMB9 (Homo sapiens) 6480464 Vitamin E results in increased expression of PSMB9 mRNA CTD PMID:19244175